Hybrid cancer drug could be resistance-resistant
Wednesday, May 25, 2016 - 10:30
in Health & Medicine
A team of cancer researchers led by scientists at UC San Francisco and Memorial Sloan Kettering Cancer Center demonstrated in human cells and mouse models that a first-of-its-kind hybrid drug can outsmart drug-resistant cancers. The new drug physically yokes together two existing drugs against a common cancer pathway into a single molecule, generating a double-blow […]